Seizure Action Plans for Pediatric Patients With Epilepsy: A Randomized Controlled Trial

Dara V F Albert1, Jennifer J Moreland2, Ann Salvator2

  • 11 Nationwide Children's Hospital/Ohio State University, Department of Pediatrics, Division of Child Neurology, Columbus, OH, USA.

Insights

Seizure action plans improve caregiver comfort and reduce missed appointments for pediatric epilepsy patients. The plans showed greater benefit for children with lower seizure frequencies, though overall healthcare utilization differences were not significant.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Management
  • Healthcare Quality Improvement

Background:

  • Seizure action plans empower patients and caregivers in managing epilepsy.
  • Effective self-management strategies are crucial for reducing epilepsy's impact.

Purpose of the Study:

  • To evaluate the impact of a seizure action plan on pediatric epilepsy patients.
  • To assess effects on healthcare utilization and family impact.

Main Methods:

  • A prospective cohort study randomly assigned pediatric epilepsy patients to receive a seizure action plan or standard care.
  • Caregivers completed the Modified Impact on Families (MIF) questionnaire.
  • Healthcare utilization and MIF scores were compared between groups.

Main Results:

  • Patients receiving a seizure action plan had significantly fewer clinic appointment no-shows (P = .04).
  • Caregivers reported higher 'Seizure comfort' scores at 12 months in the seizure action plan group, particularly for those with low seizure frequency.
  • No significant differences in other healthcare utilization measures were observed.

Conclusions:

  • Seizure action plans enhance caregiver comfort and reduce missed appointments in pediatric epilepsy care.
  • The benefits of seizure action plans may be more pronounced in patients with lower seizure frequencies.
  • Further research with larger samples is needed to fully assess impact and caregiver perceptions.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation01:24

Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation

Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
2.0K